Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis. [PDF]
BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease characterized by the presence of autoantibodies against modified proteins, known as anti-modified protein autoantibodies (AMPAs).
van Wesemael TJ +12 more
europepmc +7 more sources
Rheumatoid arthritis – usage of biomarkers in disease’ prognosing, diagnosing and monitoring [PDF]
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease which has a significant, negative influence of patients’ quality of daily life. In routine clinical practice there is a usage of classic biomarkers, such as rheumatoid factor
Sabina Skrzynecka +4 more
doaj +3 more sources
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study [PDF]
Introduction This study assesses the accuracy of neutrophil activation markers, including neutrophil extracellular traps (NETs) and calprotectin, as biomarkers of disease activity in patients with established rheumatoid arthritis (RA).
Beatriz Frade-Sosa +19 more
doaj +2 more sources
Evidence of Site-Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis. [PDF]
Objective Anti–citrullinated protein antibodies (ACPA) have been detected in sputum and saliva, indicating that anti–modified protein antibodies (AMPA) can be produced at mucosal sites in patients with rheumatoid arthritis (RA). However, the body's largest mucosal compartment, the gut, has not yet been examined.
Derksen VFAM +11 more
europepmc +2 more sources
Research progress on anti-carbamylated protein antibodies in connective tissue disease [PDF]
Connective tissue disease (CTD) is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies.
Dong Rongrong, Yang Qingrui, Ma Zhenzhen
doaj +1 more source
Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment. [PDF]
van den Beukel MD +7 more
europepmc +4 more sources
Rheumatoid arthritis and the proinflammatory cytokine IL-17 [PDF]
Introduction: Rheumatoid arthritis (RA) is the most common inflammatory joint disease. Various proinflammatory cytokines are involved in the pathogenesis of this chronic disorder.
Pavel Selimov +8 more
doaj +3 more sources
To identify the targets recognized by anti-carbamylated protein antibodies (anti-CarP) in patients with early Rheumatoid Arthritis (RA), to study the cross-reactivity between anti-CarP and anti-citrullinated protein antibodies (ACPA) and to evaluate ...
Pauline Brevet +16 more
doaj +1 more source
Detection and clinical significance of anti-carbamylated protein antibody in serologically negative patients with rheumatoid arthritis [PDF]
Objective To probe into the level and clinical significance of anti-carbamylated protein (CarP) antibody in serologically negative patients with rheumatoid arthritis (RA).
Wu Tao, Chen Chutao, Yang Lijuan, Zou Yaowei, Ma Jianda, Xu Yanhui, Jia Lei, Dai Lie
doaj +1 more source
A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered 'early'? [PDF]
Timely recognition of inflammatory and autoimmune rheumatic diseases (IARDs) is important to optimize the early diagnosis with tailored interventions and possible prevention of irreversible organ damage. This narrative review provides an update by summarizing the advances in identifying the early stages of rheumatoid arthritis, systemic sclerosis and ...
Hysa E +7 more
europepmc +2 more sources

